Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cherry on top: daily fruit may improve blood sugar and inflammation

NCT ID NCT07155915

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This pilot study tested whether eating 280 grams of sweet cherries daily for 42 days could improve metabolic health in 27 healthy adults. Researchers measured changes in blood sugar, inflammation, and other markers. The goal is to see if cherries might help prevent conditions like diabetes and heart disease, and to inform larger future studies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Sweet cherries (280 g daily)
What this could lead to
If cherries improve markers like blood sugar and inflammation, this could support using them as part of a healthy diet to reduce risk of type 2 diabetes and heart disease.
What could go wrong
This is a very small pilot study in healthy adults, so results may not apply to others. It only tests short-term effects, and any benefits might not last or be significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

27 people

The number who actually took part.

Started

May 2024

Finished

Jul 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-65 years old * Healthy individuals with no known metaboli disorders Exclusion Criteria: * Alcohol consumption * Smoking * Adverse or allergic reaction to cherries * Use of antibiotics, anxiolytics, or dietary supplements * Pregnancy or lactation * Weight changes greater than 10% in the previous year.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metabolic health are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Instituto Politécnico da Guarda

    Guarda, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.